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Abstract
Background: Molecular cloning of functional immunoglobulin genes from single plasma cells is one of the most
promising technologies for the rapid development of monoclonal antibody drugs. However, the proper insertion of
PCR-amplified immunoglobulin genes into expression vectors remains an obstacle to the high-throughput
production of recombinant monoclonal antibodies.
Results: We developed a single-step cloning method, target-selective homologous recombination (TS-HR), in
which PCR-amplified immunoglobulin variable genes were selectively inserted into vectors, even in the presence of
nonspecifically amplified DNA. TS-HR utilizes Red/ET-mediated homologous recombination with a target-selective
vector (TS-vector) with unique homology arms on its termini. Using TS-HR, immunoglobulin variable genes were
cloned directly into expression vectors by co-transforming unpurified PCR products and the TS-vector into E. coli.
Furthermore, the high cloning specificity of TS-HR allowed plasmids to be extracted from pools of transformed
bacteria without screening single colonies for correct clones. We present a one-week protocol for the production
of recombinant mouse monoclonal antibodies from large numbers of single plasma cells.
Conclusion: The time requirements and limitations of traditional cloning procedures for the production of
recombinant immunoglobulins have been significantly reduced with the development of the TS-HR cloning
technique.
Background
Molecular cloning of immunoglobulin variable (V) genes
from single isolated plasma cells is a powerful tool for
the unbiased generation of recombinant monoclonal
antibodies [1-3]. Fluorescence-activated single-cell sort-
ing followed by a single-cell reverse-transcription poly-
merase chain reaction (RT-PCR) has been shown to
enable the high-throughput production of V gene DNA
fragments [4-6]. However, the proper insertion of the V
gene DNA fragments into expression vectors remains an
obstacle to the high-throughput production of recombi-
nant monoclonal antibodies.
The most commonly employed cloning method for
introducing V gene DNA fragments into vectors is
ligation-dependent cloning [1,3,5,6]. However, ligation-
dependent cloning is often hampered by the require-
ment for multiple rounds of enzyme treatments and
purification of both the inserts and vectors. Further-
more, the limited number of appropriate restriction
enzyme sites in the insert and vector DNA limits flex-
ibility in constructing recombinant molecules. Recently,
site-specific recombination-based cloning has emerged
as a ligation-independent cloning method [7-9]. How-
ever, this technology introduces extra codons into the
gene’s primary sequence at the site of recombination,
which may interfere with the folding and stability of the
resulting protein. In contrast, homologous recombina-
tion technologies enable the seamless insertion of any
DNA fragment at any desired position [10]. Recently,
In-Fusion homologous recombination, which can join a
DNA fragment and a linear vector with 15 bases of
homology at their ends, was used in the production of
recombinant monoclonal antibodies [11]. Although the
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high-throughput procedure, the amplified V gene DNA
fragments must be purified to remove salts, primers and
nonspecifically amplified DNA before the reaction. Sub-
sequent steps are also necessary to screen single colo-
nies for a correct clone, which can result in additional
labor and increased cost. Thus, a method for the high-
throughput cloning of PCR-amplified V gene DNA frag-
ments into vectors that bypasses these tedious prelimin-
ary steps is needed.
We have developed a method, termed target-selective
homologous recombination (TS-HR), in which PCR-
amplified V gene DNA fragments can be selectively
cloned into vectors, even in the presence of nonspecifi-
cally amplified PCR products. This system, together with
the additional methods described herein, circumvents the
problems associated with the amplification and cloning of
V gene DNA fragments and provides a system for the
high-throughput production of recombinant mouse
monoclonal antibodies from large numbers of single
plasma cells within a one-week time span (Figure 1).
Results and Discussion
Low cloning specificity in conventional, Red/ET-mediated
homologous recombination
Red/ET-mediated recombination is a powerful homolo-
gous recombination system based on the function of
either the Red operon of lambda phage or RecE/RecT
from Rac phage [12-15]. To evaluate the cloning specifi-
city of conventional Red/ET-mediated homologous
recombination, we conducted a pilot experiment using a
linear nonselective vector (NS-vector) and an artificially
amplified V gene and mock DNA. The V gene was com-
posed of an upper primer-derived sequence (P1), a poly-
dG/dC sequence (T1), a human VH sequence, part of
the constant gene sequence (T2) and a lower primer-
derived sequence (P2). The mock DNA was composed
of the P1 sequence, part of the GFP sequence and the
P2 sequence. The linear NS-vector contained homology
arms at its ends (VP1 and VP2) that were homologous
to the P1 and P2 sequences, respectively (Figure 2A,
left). When the V gene and the mock DNA were mixed
in a 1:1 molar ratio and introduced into competent cells
with the NS-vector, each DNA fragment was inserted
into the NS-vector with the same probability (Figure 2B,
upper left). Transformation of the bacteria with the V
gene and the mock DNA fragment in a 1:4 molar ratio
resulted in the insertion of the V gene in 25% of the
clones (10 out of 40 clones) (Figure 2B, lower left).
Because the conventional homologous recombination
reaction was mediated through the primer-derived
sequences, the DNA fragments containing the primer
sequences at their ends were non-selectively inserted
into the NS vector.
High cloning specificity of TS-HR
To selectively clone the V gene, even in the presence of
nonspecific amplified DNA, we constructed a new vec-
tor: the target-selective vector (TS-vector). The TS-vec-
tor has homology arms (VP1-VT1 and VP2-VT2) on its
ends. The VP1 (VP2) sequence shares homology with
the P1 (P2) sequence, which is a primer-derived
sequence. VT1 (VT2) shares homology with T1 (T2),
which is a part of the V gene-specific sequence internal
to P1 (P2) (Figure 2A, right). When the V gene and the
mock DNA were mixed in a 1:1 molar ratio and intro-
duced into competent cells with the linear TS-vector,
92.5% of the analyzed colonies contained the V gene
(Figure 2B, upper right). Transformation of the bacteria
with the V gene and the mock DNA in a 1:4 molar ratio
resulted in the insertion of the V gene in 72.5% of the
analyzed colonies (29 out of 40 clones) (Figure 2B,
lower right). This result confirms the high cloning
Figure 1 Flow chart summarizing the production of
recombinant antibodies from single plasma cells.3 ’
Homopolymer-tailed cDNA was synthesized from single plasma cells
by droplet-based solid-phase cDNA synthesis. The VH and VL genes
were amplified by two rounds of PCR. The unpurified VH and VL
genes were directly inserted into the corresponding vectors by TS-
HR. After the transformation, the bacteria were directly cultured in
liquid medium, and pools of expression plasmids were extracted
without screening single colonies for correct clones. The cognate
pairs of the expression plasmids were co-transfected into 293FT
cells. Two days after the transfection, the antibodies secreted into
the cell culture medium were tested for reactivity by ELISA.
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of an excess amount of nonspecific amplified DNA.
The mechanism for selective cloning in the TS-vector
is illustrated in Figure 3. The 5’ ends of the linear DNA
are removed by the Reda 5’®3’ exonuclease in E. coli,
resulting in the generation of 3’ single-stranded tails from
the TS-vector, target and non-target DNA. When the sin-
gle-stranded tails of the target DNA anneal to the com-
plementary single-stranded tails of the TS-vector through
the long homology overlaps (P1-T1 to VP1-VT1 and P2-
T2 to VP2-VT2), the recombination reaction proceeds
via route I. When the single-stranded tails of the mock
DNA anneal to the complementary single-stranded tails
of the TS-vector through the short homology overlaps
(P1 to VP1 and P2 to VP2), the recombination reaction
proceeds via route III. However, the route I reaction
dominates over the route III reaction because the homo-
logous recombination reaction depends on the length of
the homology overlap. The homologous recombination
reaction also proceeds when the single-stranded tails of
the TS-vector anneal to the complementary single-
stranded tails of the target DNA (Figure 3, route II).
However, the homologous recombination reaction does
not proceed when the single-stranded tails of the TS-vec-
tor anneal to the single-stranded tails of the mock DNA.
The 3’ ends of the single-stranded tails of the TS vector
(VT1 and VT2) fail to serve as primers for strand exten-
sion due to the 3’ end mismatches (Figure 3, route IV).
Application of TS-HR for high-throughput production of
recombinant mouse antibodies
To demonstrate the usefulness of TS-HR, we amplified
the variable region of the immunoglobulin heavy chain
(VH) and the variable region of the immunoglobulin
light chain (VL) genes from single mouse plasma cells
by 5’ RACE PCR and attempted to insert the fragments
into the expression vectors. The pairs of VH and VL
genes were successfully amplified from single plasma
cells (Figure 4A). When conventional Red/ET-mediated
homologous recombination was conducted with a non-
selective vector (pNS-mIgG) and unpurified PCR pro-
ducts from lane 9 or 13, only 50% and 30% of the colo-
nies contained the VH gene were obtained, respectively
(Figure 4B, upper). These results clearly indicate that
purification of the V gene is required prior to the con-
ventional homologous recombination reaction. However,
when TS-HR was conducted with a V gene-selective
vector (pTS-mIgG) and unpurified PCR products from
lane 9 or 13, 80% and 90% of the colonies contained the
VH gene were obtained, respectively (Figure 4B, lower).
Theses results were in good agreement with the pilot
experiment in Figure 2.
In light of the high cloning specificity of the TS-HR
technique, we prepared the immunoglobulin expression
plasmids without screening single colonies for a correct
clone. When the pool of plasmids was extracted from
the bacteria directly cultured in liquid medium after
Figure 2 Pilot experiment demonstrating the cloning specificity of the TS-HR technique. (A) Schematic representation of the homologous
regions between the vectors and the DNA fragments. (B) Result of the conventional homologous recombination (left) and the TS-HR method
(right). The PCR-amplified V gene sequence and mock DNA were mixed in the indicated molar ratios and introduced into E. coli with either non-
selective (pNS-hIgG) or selective vector (pTS-hIgG). Colony PCR was performed, and the amplified DNA fragments were separated by agarose gel
electrophoresis. Forty colonies were analyzed, and data from a representative experiment are presented; the cloning specificity is expressed as a
percentage of the total number of colonies analyzed.
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insert of the expected size (Figure 4C). Furthermore, the
V gene DNA sequence was present in all of the plas-
mids examined, and the cloning reaction proceeded as
expected, with no insertions or deletions at the cloning
junctions (Figure 4D and Table 1). We also observed
the successful in-frame insertion of VH genes belonging
to G1, G2a and G2b, indicating the unbiased insertion
of the IgG subclass (Table 1).
Co-transfection of the cognate pair of heavy chain and
light chain expression plasmids into 293FT cells resulted
in the secretion of recombinant antibodies (19 out of
20); seven clones specifically reacted with the antigen
(Figure 5).
The major advantages of the TS-HR system include its
specificity, rapidity and robustness. By using the TS-HR
technique, the time-consuming processes inherent in
current cloning methods, such as the purification of the
V gene DNA fragment and the plating of transformed
bacteria to screen single colonies for correct clones, are
dramatically reduced. Due to the simplicity of our sys-
tem, dozens of expression plasmids can be produced
simultaneously, enabling us to produce recombinant
antibodies from large numbers of single plasma cells. In
addition, unlike other cloning systems, Red/ET-mediated
recombination can be performed inexpensively in large
quantities, saving investigators significant time and
expense. The TS-HR system can be applied to the selec-
tive cloning of DNA fragments in which primer regions
and their internal gene-specific sequences are constant
but the intervening regions vary; T-cell receptor genes
are an example of such a target sequence.
Conclusion
The method described here overcomes several major
obstacles to the cloning of PCR-amplified V gene DNA
fragments into expression vectors. First, unlike currently
employed cloning techniques, the TS-HR method does
not require purification of the V gene. Second, TS-HR
does not require the screening of transformed bacterial
colonies for correct clones. These features suggest that
TS-HR is directly applicable to high-throughput
applications.
Methods
Materials
The animal experiments in this study were approved by
the Committee on Animal Experimentation at the Uni-
versity of Toyama. Seven-week-old female ICR mice
were immunized twice (at intervals of one month)
Figure 3 Schematic illustration of TS-HR.I nE. coli, linear DNA was digested by the Reda 5’®3’ exonuclease, resulting in the generation of 3’
single-stranded tails. Homologous recombination of the V gene strands and the TS-vector, which is mediated by the long overlapping
sequences (~50 bp), proceeds by 3’ end extension from P1 and P2 (route I). However, homologous recombination of the mock DNA strands and
the TS-vector is inefficient because of their short overlapping sequences (route III). Homologous recombination of the TS-vector and the V gene,
which is mediated through the long overlapping sequences (~50 bp), proceeds by 3’ end extension from VT1 and VT2 (route II). However,
homologous recombination of the TS vector and the mock DNA does not occur because strand extension from VT1 and VT2 is blocked by 3’
end mismatches (route IV).
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Page 4 of 8Figure 4 High-throughput production of recombinant mouse monoclonal antibodies by the TS-HR technique. (A) Amplification of
cognate pairs of VH and VL genes from single plasma cells by 5’ RACE PCR. (B) The PCR product obtained (A, upper, lane 9 and 13) was directly
inserted into pNS-mIgG by conventional homologous recombination (upper) or into pTS-mIgG by TS-HR (lower). After the transformation,
bacteria were plated on agar plates containing 1% sucrose and kanamycin. Ten colonies were cultured, and plasmids were extracted from the
overnight culture. Plasmids digested with SalI/NotI were electrophoresed in a 1% agarose gel. (C) The amplified VH and VL genes obtained in (A)
were directly cloned into linear pTS-mIgG and pTS-mIgK, respectively, by TS-HR. After the transformation, bacteria were directly inoculated into
LB medium containing 1% sucrose and 50 μg/ml of kanamycin, and pools of plasmids were prepared from the overnight culture. Plasmids
digested with SalI/NotI were electrophoresed in a 1% agarose gel. (D) DNA sequencing of the plasmid obtained in (C) confirmed the in-frame
insertion of the V gene into the plasmid. A representative sequence of data from the plasmid originating from (C, upper) lane 9 is shown; the
arrow indicates the DNA fragment-vector junction of the Ig constant gene.
Table 1 V-(D)-J repertoire of cloned V genes.
Gamma Chain Kappa Chain
V D J isotype V J
1 IGHV10-1*01 IGHD2-4*01 IGHJ3*01 G2b IGKV6-32*01 IGKJ5*01
2 IGHV1-5*01 IGHD2-4*01 IGHJ1*03 G2a IGKV1-117*01 IGKJ4*02
3 IGHV1-4*01 IGHD1-1*02 IGHJ1*03 G1 IGKV6-15*01 IGKJ5*01
4 IGHV1-26*01 IGHD4-1*02 IGHJ2*01 G2b IGKV6-17*01 IGKJ1*01
5 IGHV5-17*01 IGHD2-3*01 IGHJ3*01 G2b IGKV5-43*01 IGKJ5*01
6 IGHV4-1*01 IGHD3-2*01 IGHJ2*01 G1 IGKV6-23*01 IGKJ4*01
7 IGHV1-22*01 IGHD2-12*01 IGHJ3*01 G1 IGKV14-111*01 IGKJ4*01
8 IGHV1-26*01 IGHD2-2*01 IGHJ3*01 G1 IGKV4-78*01 IGKJ1*01
9 IGHV5-17*01 IGHD2-3*01 IGHJ3*01 G2b IGKV5-43*01 IGKJ5*01
10 IGHV5-16*01 IGHD3-2*01 IGHJ2*01 G1 IGKV6-20*01 IGKJ4*02
11 IGHV1-19*01 IGHD4-1*01 IGHJ2*01(a) G1 IGKV1-135*01 IGKJ2*03
12 IGHV1-9*01 Not identified IGHJ4*01 G2b IGKV1-99*01 IGKJ1*01
13 IGHV1-62-2*01 IGHD1-1*01 IGHJ2*01(a) G2a IGKV12-46*01 IGKJ1*01
14 IGHV1-70*01(p) IGHD3-1*01 IGHJ4*01 G1 IGKV1-117*01 IGKJ2*01
15 IGHV8-12*01 IGHD1-1*01 IGHJ1*01 G1 IGKV10-96*01 IGKJ1*01
16 IGHV5-4*01 IGHD4-1*01 IGHJ1*03 G1 IGKV10-94*03/08 IGKJ1*01
17 IGHV1-53*01 IGHD1-1*01 IGHJ2*01 G2b IGKV12-41*01 IGKJ1*01
18 IGHV1-22*01 IGHD2-12*01 IGHJ3*01 G1 IGKV14-111*01 IGKJ4*01 or 02
19 IGHV1-66*01 IGHD1-1*01 IGHJ2*01(a) G1 IGKV5-45*01 IGKJ2*03
20 IGHV5-16*01 IGHD3-3*01 IGHJ1*03 G2b IGKV1-115*01(p) IGKJ5*01
Pools of plasmids originating as described in Figure 4C were sequenced, and their V-(D)-J-(H) repertoires were determined.
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Page 5 of 8intradermally in the footpad with 50 μl of a 50:50 water-
in-oil emulsion containing 25 μgo fe g ga l b u m i n
(Nakarai Tesque). Two to four weeks after the second
immunization, popliteal lymph nodes were surgically
removed, and plasma cells were isolated using the
CD138+ plasma cell isolation kit according to the man-
ufacturer’s instructions (Miltenyi Biotec). The isolated
plasma cells were microscopically identified after stain-
ing with an anti-CD138 antibody. Single cells were cap-
tured with a standard micromanipulator mounted on an
inverted microscope and suspended in 3 μl of a lysis/
binding solution (100 mM Tris HCl pH 7.5, 500 mM
LiCl, 1% lithium dodecyl sulfate and 5 mM dithiothrei-
tol) containing 3 μg of oligo-dT magnetic beads.
Synthesis of 3’ homopolymer-tailed cDNA from
single cells
3’ Homopolymer-tailed cDNA from single plasma cells
was prepared by a droplet-based solid-phase cDNA
synthesis termed Magnetic-beads Reaction through
Arrayed Hanging Drops (MAGrahd), which is described
in more detail below. Briefly, 3 μl each of single-cell
lysate containing oligo-dT magnetic beads, washing
solution 1 (10 mM Tris HCl pH 7.5, 150 mM LiCl, 0.1%
lithium dodecyl sulfate and 1 mM EDTA), washing solu-
tion 2 (75 mM KCl, 3 mM MgCl2, 0.1% Triton X-100, 5
mM DTT and 2 units of RNase inhibitor), reverse tran-
scription solution (washing solution 2 containing 10
units of SuperScript III reverse transcriptase), washing
solution 3 (50 mM potassium phosphate pH 7.0, 0.1%
Triton X-100 and 4 mM MgCl2), terminal transferase
solution (washing solution 3 containing 10 units of
terminal deoxynucleotidyl transferase), washing solution
4 (TE buffer containing 0.1% Triton X-100) and PCR
solution (1x ExTaq buffer containing 0.1 mM dNTPs
and 0.1% Triton X-100) were deposited on the surface
of a hydrophobic film to form a droplet.
The mRNA immobilized on the magnetic beads was
extracted from the cell lysis droplet with an externally
applied magnetic force and sequentially transferred into
droplets of washing solution 1, washing solution 2 and
the reverse transcription solution. After 15 minutes of
reverse transcription at 37°C, the cDNA immobilized on
the magnetic beads was sequentially transferred into a
droplet of washing solution 3 and a droplet of terminal
transferase solution for 3’ poly-dG tailing. After the
terminal transferase reaction had proceeded for 15 min-
utes at 37°C, the homopolymer-tailed cDNA immobi-
lized on the magnetic beads was sequentially transferred
into droplets of washing solution 4 and PCR solution.
Amplification of VH and VL genes from single plasma
cells
DNA fragments of the VH and VL chain genes from
single mouse plasma cells were amplified by the rapid
amplification of the 5’ cDNA ends by polymerase chain
reaction (5’ RACE-PCR) [16]. Briefly, the first round of
PCR was performed with a forward primer (AP3dC-S)
specific for the homopolymer-tail and reverse primers
specific for the respective immunoglobulins’ gamma and
kappa constant regions (mIgG1st-AS and mIgK1st-AS).
The second round of PCR was performed with a for-
ward primer (MCSAP3-S) that annealed to the first PCR
forward primer and with the respective nested reverse
primer specific for the IgG (mIgG2nd-AS) or IgK
(mIgK2nd-AS) constant regions. The PCR primers used
for the amplification of the mouse VH and VL genes are
detailed in Table 2. PCR was performed using the
ExTaq DNA polymerase in a BIO-RAD MyCycler
(35 cycles of reaction at 94°C for 30 seconds, 68°C for
40 seconds and a final extension at 72°C for 3 minutes).
Plasmid construction
A human IgG constant region was amplified by RT-PCR
with human B cell cDNA as a template. An 882-bp
DNA fragment encoding the human IgG constant
gene (596-1478 of the nucleotide accession number
AK301389) was amplified by PCR with the primer 596/
617-S (5’– GCCCGGGATCCGATATCACGTGGAACT-
CAGGCGCCCTGACC–3’, restriction enzyme sequences
Figure 5 Expression of recombinant mouse antibodies. (A) The
concentration of the recombinant antibodies in the supernatant of
cultured 293FT cells was determined by sandwich ELISA. N indicates a
negative control; all of the incubation steps were identical, except that
non-transfected cell culture medium was used. (B) The specific activity
of the recombinant antibodies was expressed as RLU/s/IgG (μg).
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Page 6 of 8underlined) and 1478-AS (5’–GAGTCGCGGCCGCCGT
CGCACTCATTTACCCGGAG–3’). The amplified gene
was digested with BamHIa n dNotI and subcloned into
the BamHI/NotI sites of the pDsRed2-N1 vector (Clon-
tech) to construct phIgG-C. The sacB gene was ampli-
fied from the pDNR1 vector (Clontech) by PCR with the
primers 5’–CCCGATATCGATCCGACGTCCACATA-
TACC-3’ and 5’-CACGTGATATCGGCATTTTCT
TTTGC–3’,d i g e s t e dw i t hEcoRV and inserted into the
EcoRV site of phIgG-C to construct pIn-hIgG. The
dC13/dG13 linker DNA was generated by annealing the
oligonucleotides 5’–GATCCCCCCCCCCCCCGATATC-
3’ and 5’–GATCGATATCGGGGGGGGGGGG -3’ and
inserting the fragment into the BamHI site of phIgG-C
to produce the V gene-selective vector pTS-hIgG. A
non-selective vector, pNS-hIgG, was amplified from
pTS-hIgG by PCR with the primers 618/642-S (5’–
CAGCGGCGTGCACACCTTCCCGGCT–3’)a n dA P 3
MCS-AS (5’–TCCCGGGCCCGCGGTACCGTCGACTG
CAGAATTCGAAG–3’).
The mock DNA fragment and the V gene DNA frag-
ment used for the pilot experiments were amplified by
PCR using plasmids as templates; the primers used were
an upper primer, MCSAP3-S and a lower primer, 618/
642-AS (5’– AGCCGGGAAGGTGTGCACGCCGCTG
–3’) .T h em o c kf r a g m e n t( 6 2 8b p )c o n s i s t e do ft h e
upper primer-derived sequence (P1 region), part of the
G F Pg e n es e q u e n c e( n o n - t a r g e tD N A )a n dt h el o w e r
primer-derived sequence (P2 region). The target DNA
fragment (683 bp) consisted of the upper primer-derived
sequence (P1 region), the poly-dC/dG sequence (T1
region), the human immunoglobulin VH region, part of
the human immunoglobulin gamma heavy chain con-
stant region that included nucleotides 596-617 (T2
region) and the lower primer-derived sequence (P2
region). The amplified DNA fragments were purified by
S-400 spin column. A schematic illustration of the DNA
fragment and the vectors is shown in Figure 2A.
A DNA fragment encoding 901 bp of the mouse IgG
constant region (559-1460 of nucleotide accession num-
ber AB097849) was amplified with the primers 5’–
GATATCACGTGTGCCTGGTCAAGGGCTATTTCC
CTGAG-3’ (restriction site underlined) and 5’– CT
CCGCGGCCGCTGGGATCATTTACCAGGAGAGT-3’.
A DNA fragment encoding 309 bp of the mouse IgK con-
stant region (441-750 of nucleotide accession number
AF466770) was amplified with the primers 5’–GATAT-
CACGTGCTGTATCCATCTTCCCACCATCC-3’ and 5’–
TCTCGCGGCCGCTGTCTCTAACACTCATTCCTG-3’.
The pTS-mIgG and pTS-mIgK plasmids were constructed
by replacing the human IgG constant gene of pTS-hIgG
with the PmlI/NotI-digested mouse IgG or IgK constant
region, respectively. A linear pNS-mIgG, a non-selective
vector, was amplified from pTS-mIgG by PCR with the pri-
mers MCSAP3-AS and mIgG2nd-S (5’– TGCCTGGT
CAAGGGCTATTTCCCTGAG-3’).
Red/ET-mediated recombination
Red/ET-mediated recombination was carried out as
described previously [15]. Vectors were linearized out-
side of the homology region by digestion with EcoRV.
T h el i n e a rv e c t o r( 0 . 1μg) and the PCR-amplified DNA
were mixed in a 1:2 molar ratio and transformed into
competent cells. After recombination, bacteria were pla-
ted on agar plates containing 1% sucrose and 50 μg/ml
kanamycin or directly inoculated into LB medium
containing 1% sucrose and 50 μg/ml kanamycin.
Colony PCR
Bacterial colonies were suspended in 100 μl of PBS-0.1%
Triton X-100 solution and heated at 95°C for 5 minutes
to extract the plasmid DNA. For PCR, 10 pmol of
primers (MCSAP3-S and 618/642-AS) was added to 1 μl
of the above cell-body heat-extracted solution, and PCR
was performed in 50 μl of a reaction system using the
ExTaq DNA polymerase (30 cycles of reaction at 94°C
for 30 seconds and 68°C for 40 seconds).
Sequence analysis
Nucleotide sequences were determined with an Applied
Biosystems 373 DNA sequencer using a BigDye Termina-
tor v.3.1 Cycle Sequence Kit (Applied Biosystems). The
V-(D)-J sequences were aligned with IMGT/V-QUEST
(http://imgt.cines.fr/IMGT_vquest/share/textes/)[17].
Expression of recombinant mouse antibodies
5’ RACE-amplified mouse VH and VL genes were
cloned in-frame into pTS-mIgG and pTS-mIgK using
Table 2 Primers used for amplifying the mouse VH and VL genes.
Use Primer Sequence
1st PCR upper AP3dC-S CGGTACCGCGGGCCCGGGATCCCCCCCCCCCCCDN
2nd PCR upper MCSAP3-S CTTCGAATTCTGCAGTCGACGGTACCGCGGGCCCGGGA
IgG 1st PCR lower mIgG1st-AS ACCYTGCATTTGAACTCCTTGCC
IgG 2nd PCR lower mIgG2nd-AS CTGGACAGGGATCCAGAGTTCCA
IgK 1st PCR lower mIgK1st-AS ACTGCCATCAATCTTCCACTTGACA
IgK 2nd PCR lower mIgK2nd-AS ACTGAGGCACCTCCAGATGTTAACT
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Page 7 of 8TS-HR methodology. Plasmids were purified with Pure-
Yield Plasmid Miniprep kits (Promega). Cognate pairs of
VH and VL genes were co-transfected into 293FT cells
grown in 24-well culture dishes with FuGENE HD
Transfection Reagent (Roche). Two days after transfec-
tion, cell culture supernatants were analyzed for the
secretion of recombinant antibodies. The antibody con-
centration and antibody reactivity were determined by a
sandwich enzyme-linked immunosorbent assay (ELISA).
Briefly, high-binding-capacity ELISA plates (Corning)
that were pre-coated with either goat anti-mouse IgG
(Sigma) or egg albumin were incubated for 1 h with 200
μl of DMEM containing 10% FBS for blocking. After
washing the plates 3x with PBS, the cell-culture super-
natant was transferred into the ELISA plates and incu-
bated for 2 h at room temperature. After washing the
plates with PBS, 100 μl of alkaline phosphatase (AP)-
conjugated goat anti-mouse IgG (Sigma) at a concentra-
tion of 0.8 μg/ml in PBS was added to the wells and
incubated for 2 h. After washing with PBS, the assays
were developed using BM Chemiluminescence ELISA
Substrate (AP) (Roche) and quantified with a Tecan
GENios microplate reader (TECAN, Crailsheim, Ger-
many). The magnitude of the light emission was
expressed as relative light units (RLU).
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